Fulvestrant-D3 can be intended for use as an internal standard for the quantification of Fulvestrantby GC- or LC-mass spectrometry.
A novel labelled steroidal estrogen antagonist, Fulvestrant-D3 can be reported to lack any partial agonist activity. Antineoplastic (hormonal).
A novel labelled steroidal estrogen antagonist reported to lack any partial agonist activity. Antineoplastic (hormonal).
